The operational problem
A crew traveling far from Earth may need compact tools that are easy to store, simple to activate, and realistic for astronauts to use with limited time and equipment.
Genes in Space · Award-Winning Proposal
Genes in Space
Validating a Cell-Free CRISPR Fluorescent RNA Diagnostic in Microgravity
Aryash Shyam designed a safe, low-resource experiment to test whether a freeze-dried, cell-free CRISPR-Cas13 system could detect a synthetic RNA target and produce a visible fluorescent signal in microgravity.
CRISPR-Cas13
Space Biology
Cell-Free Diagnostics
Experimental Design
1
Synthetic RNA Target
4
Experimental Groups
2
Genes in Space Tools
Green
Fluorescent Readout
Project Overview
Could astronauts monitor molecular changes without a full laboratory?
Aryash’s Genes in Space project proposes a proof-of-concept experiment for autonomous molecular monitoring during long-duration spaceflight. The assay uses freeze-dried BioBits reactions to produce CRISPR-Cas13 and a target-specific guide RNA. After rehydration, the presence of a defined synthetic RNA target should activate Cas13 collateral cleavage and create a green fluorescent signal visible with a handheld viewer.
The Space Biology Challenge
Health monitoring becomes harder when Earth-based laboratories are far away
Long-duration spaceflight can alter cellular regulation and molecular biomarkers. Detecting those changes during a mission is difficult when conventional tests require complex sample processing, living cells, heavy instruments, or ground-based laboratory support.
The scientific question
Microgravity changes fluid behavior and removes buoyancy-driven convection. Aryash’s experiment asks whether those conditions could affect reaction efficiency or the consistency of a CRISPR-based fluorescent signal.
How the Diagnostic Works
Add water. Detect the RNA. Look for the glow.
The design removes living cells from the workflow and uses a safe synthetic RNA sequence so the experiment can focus on the diagnostic platform itself.
Freeze-Dried Reaction
BioBits components are stored in a lyophilized, cell-free format suitable for compact transport.
Rehydrate
Water activates production of CRISPR-Cas13 and the target-specific guide RNA.
Recognize
If the synthetic target RNA is present, the guide directs Cas13 to the matching sequence.
Fluoresce
Activated Cas13 cleaves reporter molecules, generating a green fluorescent signal in the P51 viewer.
Expected Readout
A simple visual signal designed for a constrained environment
The experiment measures the presence and relative intensity of green fluorescence. A successful result would show fluorescence only in reactions containing the target RNA.
RNA
Target Absent
Without the matching synthetic RNA, Cas13 should remain inactive and the reporter should not produce a meaningful fluorescent signal.
→
Glow
Target Present
Recognition of the target should activate Cas13 collateral cleavage and create visible green fluorescence.
Experimental Controls
Four groups separate target detection from background signal
Aryash designed matched spaceflight and ground-control conditions, with and without the target RNA.
Tools & Technology
A compact platform built around cell-free biology and fluorescence
BioBits Cell-Free System
BioBits enables on-demand production of CRISPR-Cas13 components without transporting or maintaining living cells. The freeze-dried format supports storage, portability, and simple activation.
P51 Molecular Fluorescence Viewer
The handheld viewer is used to observe and photograph the green fluorescent reporter signal, allowing comparison between spaceflight and ground samples.
Skills Demonstrated
Designing science that is safe, controlled, specific, and realistic
Defined the mission problem
Focused on autonomous molecular monitoring during long-duration missions far from Earth.
Reduced biological risk
Selected a safe synthetic RNA target rather than requiring astronaut samples or infectious material.
Built clear controls
Created matched positive and negative groups in spaceflight and ground conditions.
Designed for operations
Used freeze-dried, cell-free reactions and a handheld fluorescence viewer to minimize equipment and crew burden.
Why It Matters
Technology designed for space can also strengthen diagnostics on Earth
For Long-Duration Spaceflight
A validated platform could support future development of compact molecular tests that help crews monitor physiological stress, disease-related biomarkers, or other health changes without relying on immediate access to Earth-based laboratories.
For Remote and Low-Resource Settings
Freeze-dried, instrument-light diagnostics could also benefit communities, clinics, and patients far from major laboratories, where portability and simple operation are especially valuable.
Limitations & Next Steps
A platform-validation experiment, not a clinical astronaut diagnostic
Current scope
The proposal uses a defined synthetic RNA sequence to isolate the behavior of the diagnostic platform. It does not test astronaut samples, diagnose disease, or establish clinical performance. Its purpose is to determine whether the core cell-free Cas13 detection mechanism can produce a reliable signal in microgravity.
Compare signal consistency
Analyze fluorescence intensity across spaceflight and ground samples using astronaut-acquired images.
Expand to real biomarkers
Adapt the platform to physiological stress or disease-related RNA targets after the core mechanism is validated.
Improve autonomy
Refine storage, rehydration, imaging, and analysis for increasingly self-contained crew use.
Frequently Asked Questions
About Aryash’s Genes in Space project
What is Aryash Shyam’s Genes in Space project?
It is a proposed microgravity experiment that tests whether a freeze-dried, cell-free CRISPR-Cas13 system can detect a safe synthetic RNA target and generate a green fluorescent signal.
Why use CRISPR-Cas13?
Cas13 can be programmed to recognize a specific RNA sequence. When it detects the target, collateral cleavage can activate a fluorescent reporter, creating a visible readout.
Why is the target RNA synthetic?
A synthetic RNA target improves safety and experimental control. It avoids astronaut biological samples and allows the study to isolate whether the diagnostic mechanism itself functions in microgravity.
What are the four experimental groups?
The design compares spaceflight reactions with and without target RNA against identical ground-control reactions with and without target RNA.
What result would support the hypothesis?
Fluorescence should occur in target-containing reactions and remain absent or minimal in no-target controls, with spaceflight performance compared against the matched ground samples.
Has this been validated as a medical diagnostic?
No. The project is a platform-validation proposal using a synthetic target. It is not a clinical diagnostic and does not test astronaut health samples.
The Bigger Idea
A small fluorescent reaction could become an early step toward autonomous molecular health monitoring
Aryash’s project shows how CRISPR, cell-free biology, and careful experimental controls can be combined into a compact concept designed for the realities of spaceflight—and potentially for places on Earth where advanced laboratory access is limited.